Product correctly added to cart.

discount label
Tyrphostin B44, (+) enantiomer
View 3D

Biosynth logo

Tyrphostin B44, (+) enantiomer

CAS: 133550-37-5

Ref. 3D-IFA55037

10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
250mgTo inquire
Estimated delivery in United States, on Friday 28 Jun 2024

Product Information

Name:
Tyrphostin B44, (+) enantiomer
Synonyms:
  • Ag 835
  • Alpha-Cyano-(+)-(S)-N-(Alpha-Phenethyl)-(3,4-Dihydroxy)Cinnamide
  • (S)-(E)-2-Cyano-3-(3',4'-Dihydroxyphenyl)-N-(1-Phenylethyl)-2-Propenamide
  • (+)-(S)-N-(Alpha-Methylbenzyl)-3,4-Dihydroxy-Benzylidenecyanoacetamide
  • Tyrphostin B44, (+) Enantiomer
  • Tyrphostin B50
  • (2E)-2-cyano-3-(3,4-dihydroxyphenyl)-N-[(1S)-1-phenylethyl]prop-2-enamide
Description:

Tyrphostin B44 is an inhibitor of tyrosine kinases. It binds to the ATP binding site on the enzyme and prevents ATP from binding, blocking the phosphorylation of the enzyme's substrate. Tyrphostin B44 has been shown to be a potent inhibitor of epidermal growth factor receptor (EGFR), which is a key regulator in inflammatory diseases. This drug also has anti-cancer effects by inhibiting lipase, which is required for cancer cell proliferation.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
308.34 g/mol
Formula:
C18H16N2O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-IFA55037 Tyrphostin B44, (+) enantiomer

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".